Natco case puts Drug Controller in poor lightFor comparison, look at the way the US FDA keeps the record straight.
November 5, 2009
For Big Pharma, there are Geneis galore in IndiaOn their part, small firms with good technologies should improve visibility and relevance.
October 22, 2009
Better monitoring of clinical research an imperativeOne instance of wrong trial data can tarnish the industry’s reputation and move investment elsewhere.
October 15, 2009
War of contraceptive pills raises issues of controlCipla and Mankind Pharma are engaged in a big battle for supremacy in the Indian oral contraceptives market.
October 7, 2009
Rumours of pharma M&As have their own reasonWith MNCs keen to tap the local market, there’s no saying who’ll draw blood next.
October 1, 2009
Merck vaccine move signals shift in Big PharmaMNC has set up firm to develop vaccines for low-income countries. Local firms should take cue
September 25, 2009
Dr Reddy’s: Promoter exit won’t come cheapDr Reddy’s officials steadfastly denied any equity dilution by the promoters but that clarification largely failed to quell the theorists.
September 17, 2009
Vaccine delay could put swine flu out of controlLast week, Novartis announced that its pilot trials on 100 volunteers for a vaccine to immunise against swine flu gave strong immune response after one dose.
September 10, 2009
Revamping legal mechanism alone can’t stop spurious drug makersFrom the times when offenders found guilty of manufacturing spurious drugs were allowed to go free with a minuscule penalty to now, when a 10-year prison and a hefty charge will be slapped, it is all a move in the right direction.
September 4, 2009
Countering H1N1 will take a concerted attackGiven reports of the virus becoming resistant to both Tamiflu and Relenza, it’s now or never.
August 14, 2009
Roche will only help itself by making drugs affordableAn otherwise media-shy or almost off-media company, Roche India, is suddenly vocal about its efforts to reduce prices of its key life-saving drugs.
August 7, 2009
Buyout by Sanofi is a good turn for Shantha BiotechnicsThe introduction of Shantha’s vaccine to fight the dreaded liver disease forced SmithKline Beecham to slash prices of its vaccine brand Engerix-B, after enjoying a monopoly market in India.
August 1, 2009
Natco recall a case to bolster drug controlPitfalls in the Indian drug regulations came to light last week when it was reported that a newly launched anti-cancer drug was asked to be withdrawn by the Drug Controller General of India.
July 23, 2009
|
ReportsOur columnists
Contributors
|
|
||||||